Quinagolide

Quinagolide
Clinical data
Trade names	Norprolac
AHFS/Drugs.com	International Drug Names
Routes of; administration	Oral
ATC code	G02CB04 (WHO)
Legal status
Legal status	℞ (Prescription only);
Identifiers
	IUPAC name N,N-diethyl-N'-[(3S,4aS,10aR)-6-hydroxy-1-propyl-1,2,3,4,4a,5,10,10a-octahydrobenzo[g]quinolin-3-yl]sulfamide;
CAS Number	87056-78-8
PubChem (CID)	55645
ChemSpider	2343034
UNII	80Q9QWN15M
KEGG	D07217
ChEMBL	CHEMBL290962
Chemical and physical data
Formula	C20H33N3O3S
Molar mass	395.56 g/mol
	InChI InChI=1S/C20H33N3O3S/c1-4-10-22-14-17(21-27(25,26)23(5-2)6-3)11-16-12-18-15(13-19(16)22)8-7-9-20(18)24/h7-9,16-17,19,21,24H,4-6,10-14H2,1-3H3/t16-,17+,19-/m1/s1 ; Key:GDFGTRDCCWFXTG-ZIFCJYIRSA-N ;
(what is this?) (verify)

Quinagolide (INN, BAN) (brand name Norprolac) is a selective D₂ receptor agonist that is used to reduce elevated levels of prolactin (hyperprolactinemia).^[1] It has also been found to be effective in the treatment of breast pain.^[2]

References[edit]

^ Antonella Di Sarno; Maria Luisa Landi; Paolo Marzullo; Carolina Di Somma; Rosario Pivonello; Gaetana Cerbone; Gaetano Lombardi; Annamaria Colao (July 2000). "The effect of quinagolide and cabergoline, two selective dopamine receptor type 2 agonists, in the treatment of prolactinomas". Clinical Endocrinology. 53 (1): 53–60. doi:10.1046/j.1365-2265.2000.01016.x. PMID 10931080.
^ Alfonso M Pluchinotta (20 April 2015). The Outpatient Breast Clinic: Aiming at Best Practice. Springer. pp. 167–. ISBN 978-3-319-15907-2.

This pharmacology-related article is a stub. You can help Wikipedia by expanding it.